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EGF receptor signalling: The importance of presentation
Christian Klämbt
Activation of the Drosophila EGF receptor requires the
transmembrane TGF-a -like ligand Spitz. Recent studies
have shed new light on the role of two transmembrane
proteins, Star and Rhomboid, in the presentation and
subsequent proteolytic processing of Spitz.
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Epidermal growth factor (EGF) signalling plays a number
of important roles in the development of both vertebrates
and invertebrates; in fulfilling these roles, the EGF recep-
tor controls a diverse range of cellular functions, such as
cell division, cell-fate decisions and differentiation [1,2].
Upon activation by an extracellular signal, the EGF recep-
tor undergoes dimerisation and autophosphorylation,
leading, via the evolutionarily conserved Ras pathway, to
modulation of the activity of specific transcription factors
in the nucleus. The complexity of cellular functions
governed by the EGF receptor implies that its activity
must be precisely regulated in the developing organism.
Recent studies on EGF receptor signalling have identified
a number of molecular components that help ensure the
pathway is regulated with the requisite precision; work on
this pathway is likely to provide important general insights
into cell–cell signalling systems.
In vertebrates, four different EGF receptor homologues
constitute the ErbB superfamily. They are activated by
small signalling molecules, such as transforming growth
factor a (TGF- a ), EGF or the Neuregulins, which are all
characterised by having one EGF-like motif in their
extracellular domain. The Neuregulins are a diverse
family of more than fifteen proteins, all generated from a
single gene. Some of the isoforms are membrane-teth-
ered and possess a long cytoplasmic domain; as in the
case of TGF- a , which is similarly generated as a trans-
membrane precursor, proteolytic processing is required to
generate the active ligand. In these cases, the cytoplas-
mic protein domains control proteolytic processing of the
extracellular domain [3,4].
In the fruitfly Drosophila, only one EGF receptor has been
identified to date, known as DER for Drosophila EGF
receptor. Four ligands are known to modulate the function
of the DER: Vein, Gurken and Spitz are activating
ligands, whereas Argos is a novel inhibitory ligand. Vein
resembles the secreted vertebrate Neuregulin isoforms,
whereas Gurken and Spitz resemble TGF-a and are
expressed as membrane-bound precursor molecules.
Mosaic studies have shown that Spitz can diffuse over
several cell diameters, suggesting that in vivo it is proteo-
lytically cleaved to generate the active ligand [5,6]. In
support of this notion, expression of secreted Spitz protein
was found to result in prominent activation of DER,
whereas expression of a membrane-bound Spitz protein
did not lead to DER activation [7]. During embryogene-
sis, DER activation appears to be mostly provoked by the
ubiquitously expressed Spitz protein.
Genetic studies revealed mutations in two other Drosophila
genes that lead to a spitz-like mutant phenotype [8]. The
rhomboid gene encodes a seven-transmembrane domain
protein; and Star encodes a protein with a single trans-
membrane domain [9,10]. Both rhomboid and Star act non-
cell autonomously to promote DER activation [11].
Indeed, localised expression of secreted Spitz in the central
nervous system (CNS) midline of a rhomboid mutant
embryo was found to rescue the mutant phenotype [12].
These observations suggested that Star and Rhomboid act
by controlling the processing of the membrane-bound
Spitz into an active, soluble DER ligand. But an elegant
series of experiments by Bang and Kintner [13] has now
provided evidence for a novel regulatory mechanism of
ligand presentation. Their results indicate that it is not the
cleavage of the membrane-bound Spitz protein that frees
its signalling capacities, but rather the presentation of Spitz
by the transmembrane proteins Rhomboid and Star that
creates an active signalling molecule. Most interestingly,
the interaction of these three proteins depends on their
transmembrane or cytoplasmic domains [13].
The experimental data supporting this model were
obtained using a modified Xenopus animal cap assay that
Bang and Kintner developed to study the regulation of
DER signalling in a highly sensitive manner (Figure 1). In
Xenopus animal cap cells, receptor tyrosine kinase activation
induces the expression of the brachyury (Xbra) gene via the
conserved Ras signalling pathway. Monitoring Xbra expres-
sion thus allows a faithful measure of receptor tyrosine
kinase activation. Animal cap cells derived from embryos
injected solely with Drosophila EGF receptor RNA were
unable to activate endogenous Ras signalling. Only when
DER, Star, rhomboid and spitz RNAs were coinjected was a
robust activation of Xbra observed [13]. As in the Drosophila
system, the requirement for Rhomboid and Star for DER
activation could be overcome by co-expression of secreted
Spitz protein. Furthermore, adding the DER inhibitor
Argos efficiently inhibited activation of the DER.
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In a number of subsequent experiments, Bang and
Kintner [13] found that Rhomboid and Star alone could
only weakly stimulate DER activation, but that they show
a strong synergistic interaction. This suggests that express-
ing either Star or Rhomboid alone, or both together, might
modulate the level of DER activation. In vivo, however,
Star and Rhomboid appear to act as co-dependent factors.
Some aspects of DER activity, most notably its function
in the developing Drosophila eye, are not affected by
rhomboid function.
Four additional ‘new’ rhomboid-like genes (rhomboid-2 to
rhomboid-5) have recently been identified in the
Drosophila genome as well as in other species, with
highest levels of sequence conservation found in the
seven transmembrane domains (M. Freeman, personal
communication). The rhomboid-3 gene is the most closely
related to the original rhomboid-1 gene. Rhomboid-1 and
Rhomboid-3 cooperate during activation of DER in the
developing eye disc, and indeed double-mutant cell
clones are phenotypically similar to DER mutant cell
clones. This finding solves the old question of how DER
could be activated in the developing compound eye in
the apparent absence of Rhomboid. The existence of
multiple Rhomboid molecules suggests that Star and
Rhomboid always function together in development and
that these proteins might form multimeric complexes (M.
Freeman, personal communication).
Where do Star and Rhomboid act? Genetic mosaic analy-
ses in Drosophila have shown that Star and Rhomboid act
non-cell autonomously [11]. Bang and Kintner [13] con-
firmed this genetic inference by simple sandwich experi-
ments. They confronted different animal cap cells
derived from Xenopus eggs injected with RNAs for DER
or Spitz alone, or a combination of Spitz, Rhomboid and
Star. These experiments showed that Star and Rhomboid
have to be expressed together with Spitz in the signalling
cell to elicit Xbra expression in the animal cap cells
expressing DER (Figure 1). Unexpectedly, this approach
revealed that expression of Rhomboid and Star in both
sending and receiving cells attenuates DER activation,
indicating another possible way that DER activity can be
fine-tuned in vivo.
How do Star and Rhomboid regulate the activity of Spitz?
In contrast to the situation in Drosophila, activation of the
human EGF receptor by TGF-a does not require the pres-
ence of Star or Rhomboid. In a simple experiment, Bang
and Kintner [13] swapped the intracellular and the trans-
membrane domains of Spitz and human TGF-a .
Surprisingly, they found that activity of the resulting
chimeric human TGF-a protein, which was properly trans-
ported to the membrane, now required Rhomboid and Star
in order to activate the human EGF receptor. Thus,
sequences located in the transmembrane or cytoplasmic
domain of Spitz keep the extracellular signalling domain
in an inactive state (Figure 2). 
The generation of the active form of TGF-a or of a
Neuregulin requires proteolytic cleavage of the ligand
from the membrane-bound precursor proteins. For DER
activation, cleavage of membrane-bound Spitz, facilitated
by Star and Rhomboid, is thought to generate the active
signalling molecule. Indeed, in media conditioned by
animal cap cells expressing Spitz, Star and Rhomboid,
Bang and Kintner [13] were able to demonstrate the
presence of soluble Spitz. To disrupt proteolytic cleavage,
potential cleavage sites in a stretch of 15 amino acids in
the extracellular domain of Spitz were removed (Figure 2).
The resulting Spitz variant still activated DER in a Star-
and Rhomboid-dependent manner, but no soluble Spitz
protein was released, indicating that proteolytic processing
of membrane-bound Spitz is not necessary for DER acti-
vation. The function of Rhomboid and Star is thus to
present Spitz to DER; this may facilitate the proteolytic
cleavage of Spitz, though this appears not to be required
for the activation of DER signalling.
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Figure 1
The Xenopus animal cap assay system used by Bang and Kintner [13]
to analyse the roles of Rhomboid and Star in DER activation.
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Where does cleavage of the Spitz precursor occur? The
results obtained with the Spitz–TGF- a chimeras, and
similarities to the proteolytic processing of Notch or
b -amyloid precursor protein by the multiple-transmem-
brane domain protein presenilin-1 [14], led Bang and
Kintner [13] to test whether Spitz too might be cleaved
within its transmembrane domain. In order to do so, they
generated a chimera combining the extracellular and
transmembrane domain of Spitz with the Notch intracel-
lular domain (NICD) lacking the previously identified
proteolytic cleavage site close to, or within, the Notch
transmembrane domain [15]. The expectation was that,
following cleavage in the transmembrane domain, the
NICD would be released, translocate to the nucleus and
activate target genes [15–17]. First of all, the chimeric
Spitz–NICD protein activated DER in a Rhomboid- and
Star-dependent manner (Figure 2). Thus, the presenta-
tion of the Spitz signal to DER works despite an
exchange of the cytoplasmic domain. Furthermore, a
Notch target gene was activated only when Rhomboid
and Star were present, suggesting that the chimeric
protein has to be cleaved in the Spitz transmembrane
domain, allowing release and subsequent translocation of
the NICD into the nucleus. Deletion of the 15 residue-
long stretch just outside the transmembrane domain did
not interfere with the Rhomboid- and Star-dependent
activation of DER, but expression of the Notch target
gene could no longer be induced. 
These observations nicely show that Rhomboid and Star
can act in a cell-autonomous fashion independently of the
DER, and suggest that the cytoplasmic domain of Spitz
might generate a signal that acts directly in the cell in which
it is produced — as has been reported for TGF-b and the
Ephrins [18,19]. Furthermore, the results show that cleav-
age of Spitz within its transmembrane domain is not neces-
sary to activate the DER. Finally, the interaction of Spitz,
Rhomboid and Star appears to depend on the nature of the
transmembrane domains, as NICD and cytoplasmic Spitz
domains do not share any sequence similarities.
The kind of role of Star and Rhomboid appear to play in
ligand presentation or facilitation of proteolytic processing
might reflect a more general property of cell–cell sig-
nalling systems. Star has been proposed to facilitate pro-
cessing of Gurken, another activating ligand of DER [20].
Notch signalling controls cell-fate determination in many
tissues, and is triggered by transmembrane ligands such as
Delta. Delta can be cleaved by the Kuzbanian metallopro-
tease, and the extracellular fragment antagonises the func-
tion of the membrane-bound Delta protein as an
activating Notch ligand [21,22]. Star has been identified as
a suppressor of Delta function [23]; reduction of Star gene
function might lead to a reduced release of the extracellu-
lar Delta fragment, and thus to enhanced Delta signalling.
It remains to be shown how Star and the different Rhom-
boids function in the regulation of this signalling pathway.
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Rhomboid and Star play essential roles in the presentation of active
Spitz ligand to the DER. (a) Spitz protein is kept at the cell surface in
an inactive state, either by formation of inactive oligomers or by a
conformational state imposed by the cytoplasmic domain. (b) When
Rhomboid and Star are present, Spitz resumes its active form, leading
to proteolytic cleavage of Spitz. Cleavage is likely to occur in the
transmembrane domain, and depends on the 15 amino-acid domain
containing potential cleavage sites. (c) A chimeric protein comprising
the extracellular and transmembrane domain of Spitz and the
intracellular domain of Notch (NICD) still activates DER in a Rhomboid-
and Star-dependent manner. In addition, NICD is released and
translocates to the nucleus to activate Notch target genes. Following
deletion of the 15 amino-acid cleavage domain, activation of DER still
occurs, but no cytoplasmic release of the NICD is observed.
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Cell Biology
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Regulation of LEF-1/TCF transcription factors by Wnt
and other signals
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In or out? Regulating nuclear transport
Jennifer K Hood and Pamela A Silver
Organization and regulation of proteins at synapses
Jee Hae Kim and Richard L Huganir
Apoptosis control by death and decoy receptors
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Deciphering the pathways of life and death
Honglin Li and Junying Yuan
Regulating the onset of mitosis
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The full text of Current Opinion in Cell Biology is in the
BioMedNet library at
http://BioMedNet.com/cbiology/jcel
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